Observational studyCancer medicine2025

Circulating Tumour DNA in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer and Early Disease Progression After First-Line Osimertinib Treatment: The ELUCIDATOR Multicentre Prospective Observational Study.

Akihiro Tamiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.